IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

OUP Management Co., LLC

Q3 2022 Holdings

Filed 2022-11-01 | 15 holdings | $64.2K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Centessa Pharmaceuticals plc(CNTA)Sponsored ADS152309100$11.8K2,937,61518.4%
PMV Pharmaceuticals, Inc.(PMVP)Common Stock69353Y103$11.8K989,23218.3%
Dice Therapeutics Inc.Common Stock23345J104$10.9K536,69316.9%
Aerovate Therapeutics Inc.Common Stock008064107$10.0K603,76215.6%
ionQ, Inc.(IONQ)Common Stock46222L108$6.0K1,177,5979.3%
Cyteir Therapeutics, Inc.Common Stock23284P103$4.7K2,469,5727.4%
Vor Biopharma Inc.Common Stock929033108$1.5K374,7142.3%
Precision BioSciences, Inc.Common Stock74019P108$1.5K1,123,9132.3%
Selecta Biosciences, Inc.(SELBUSD)Common Stock816212104$1.4K862,5432.2%
Evolv Technologies Holdings, Inc.(EVLV)Common Stock30049H102$1.4K652,4752.2%
Graphite Bio(GRPH)Common Stock38870X104$1.3K406,3082.0%
Landos Biopharma, Inc.Common Stock515069102$8041,237,6671.3%
eFFECTOR Therapeutics, Inc.Common Stock28202V108$5871,025,6970.9%
Spero Therapeutics, Inc.(SPRO)Common Stock84833T103$498249,0700.8%
Homology Medicines, Inc.Common Stock438083107$10364,0000.2%